Inhibitory effects of siegesbeckia orientalis extracts on advanced glycation end product formation and key enzymes related to metabolic syndrome

Molecules

Volumn 22, Issue 10, 2017, Pages

  Hung, Wei Chin ^a   Ling, Xue Hua ^b   Chang, Chi Chang ^b   Hsu, Hsia Fen ^b   Wang, Shih Wei ^b   Lee, Yi Chen ^a   Luo, Ci ^b   Lee, Yun Tzu ^b   Houng, Jer Yiing ^b  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Advanced glycation end products; Angiotensin I converting enzyme; Antioxidation; Lipase; Siegesbeckia orientalis linne; amylase; glucosidase

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALPHA AMYLASE PANCREAS ISOENZYME; ALPHA GLUCOSIDASE; ANTIOXIDANT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FLAVONOID; GLYCOSIDASE INHIBITOR; PLANT EXTRACT; TRIACYLGLYCEROL LIPASE;

ANTAGONISTS AND INHIBITORS; ASTERACEAE; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; HUMAN; HYPERGLYCEMIA; METABOLIC SYNDROME X; OXIDATIVE STRESS; PATHOLOGY;

ALPHA-GLUCOSIDASES; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; ASTERACEAE; FLAVONOIDS; GLYCATION END PRODUCTS, ADVANCED; GLYCOSIDE HYDROLASE INHIBITORS; HUMANS; HYPERGLYCEMIA; LIPASE; METABOLIC SYNDROME; OXIDATIVE STRESS; PANCREATIC ALPHA-AMYLASES; PLANT EXTRACTS;

EID: 85032926147     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules22101785     Document Type: Article

References (73)

1. Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. The metabolic syndrome. Lancet 2005, 365, 1415–1428. [CrossRef]
2. Sathyaprakash, R.; Henry, R.R. Preventing diabetes by treating aspects of the metabolic syndrome. Curr. Diabetes Rep. 2002, 2, 416–422. [CrossRef]
3. Nowotny, K.; Jung, T.; H hn, A.; Weber, D.; Grune, T. Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 2015, 5, 194–222. [CrossRef] [PubMed]
4. Ranilla, L.G.; Apostolidis, E.; Genovese, M.I.; Lajolo, F.M.; Shetty, K. Evaluation of indigenous grains from the Peruvian Andean region for antidiabetes and antihypertension potential using in vitro methods. J. Med. Food 2009, 12, 704–713. [CrossRef] [PubMed]
5. Shobana, S.; Sreerama, Y.N.; Malleshi, N.G. Composition and enzyme inhibitory properties of finger millet (Eleusine coracana L.) seed coat phenolics: Mode of inhibition of α-glucosidase and pancreatic amylase. Food Chem. 2009, 115, 1268–1273. [CrossRef]
6. Yao, Y.; Sang, W.; Zhou, M.; Ren, G. Antioxidant and α-glucosidase inhibitory activity of colored grains in China. J. Agric. Food Chem. 2010, 58, 770–774. [CrossRef] [PubMed]
7. Wendt, T.; Bucciarelli, L.; Qu, W.; Lu, Y.; Yan, S.F.; Stern, D.M.; Schmidt, A.M. Receptor for advanced glycation endproducts (RAGE) and vascular inflammation: Insights into the pathogenesis of macrovascular complications in diabetes. Curr. Atheroscler. Rep. 2002, 4, 228–237. [CrossRef] [PubMed]
8. Yamagishi, S.; Takeuchi, M.; Inagaki, Y.; Nakamura, K.; Imaizumi, T. Role of advanced glycation end products (AGEs) and their receptor (RAGE) in the pathogenesis of diabetic microangiopathy. Int. J. Clin. Pharm. Res. 2003, 23, 129–134.
9. Yamagishi, S.; Imaizumi, T. Diabetic vascular complications: Pathophysiology, biochemical basis and potential therapeutic strategy. Curr. Pharm. Des. 2005, 11, 2279–2299. [CrossRef] [PubMed]
10. Takenaka, K.; Yamagishi, S.; Matsui, T.; Nakamura, K.; Imaizumi, T. Role of advanced glycation end products (AGEs) in thrombogenic abnormalities in diabetes. Curr. Neurovasc. Res. 2006, 3, 73–77. [CrossRef] [PubMed]
11. Tessier, F.J. The Maillard reaction in the human body. The main discoveries and factors that affect glycation. Pathol. Biol. 2010, 58, 214–219. [CrossRef] [PubMed]
12. Cassel, C.K.; Leipzig, R.M.; Cohen, H.J.; Larson, E.B.; Meier, D.E. Geriatric Medicine, 3rd ed.; Springer: New York, NY, USA, 1997; pp. 7–25.
13. Katayama, S.; Haga, Y.; Saeki, H. Loss of filament-forming ability of myosin by non-enzymatic glycosylation and its molecular mechanism. FEBS Lett. 2004, 575, 9–13. [CrossRef] [PubMed]
14. Goh, S.Y.; Cooper, M.E. Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 2008, 93, 1143–1152. [CrossRef] [PubMed]
15. Oliveira, M.I.A.; Souza, E.M.; Pedrosa, F.O.; Réa, R.R.; Alves, A.S.C.; Picheth, G.; Rego, F.G.M. RAGE receptor and its soluble isoforms in diabetes mellitus complications. J. Bras. Patol. Med. Lab. 2013, 49, 97–108. [CrossRef]
16. Tsuji-Naito, K.; Saeki, H.; Hamano, M. Inhibitory effects of Chrysanthemum species extracts on formation of advanced glycation end-products. Food Chem. 2009, 116, 854–859. [CrossRef]
17. Balasubramaniam, V.; Mustar, S.; Khalid, N.M.; Rashed, A.; Noh, M.F.M.; Wilcox, M.; Chater, P.; Brownlee, I.; Pearson, J.P. Inhibitory activities of three Malaysian edible seaweeds on lipase and α-amylase. J. Appl. Phycol. 2013, 25, 1405–1412. [CrossRef]
18. Zhang, B.; Deng, Z.; Ramdath, D.D.; Tang, Y.; Chen, P.X.; Liu, R.; Liu, Q.; Tsao, R. Phenolic profiles of 20 Canadian lentil cultivars and their contribution to antioxidant activity and inhibitory effects on α-glucosidase and pancreatic lipase. Food Chem. 2015, 172, 862–872. [CrossRef] [PubMed]
19. Lean, M.; Lara, J.; O’Hill, J. ABC of obesity: Strategies for preventing obesity. Br. Med. J. 2006, 333, 959–962. [CrossRef] [PubMed]
20. Rana, J.S.; Nieuwdorp, M.; Jukema, J.W.; Kastelein, J.J. Cardiovascular metabolic syndrome—An interplay of, obesity, inflammation, diabetes and coronary heart disease. Diabetes Obes. Metab. 2007, 9, 218–232. [CrossRef] [PubMed]
21. Bogaert, Y.E.; Linas, S. The role of obesity in the pathogenesis of hypertension. Nat. Clin. Pract. Nephrol. 2009, 5, 101–111. [CrossRef] [PubMed]
22. Shi, Y.G.; Burn, P. Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity. Nat. Rev. Drug Discov. 2004, 3, 695–710. [CrossRef] [PubMed]
23. Ranilla, L.G.; Kwon, Y.I.; Apostolidis, E.; Shetty, K. Phenolic compounds, antioxidant activity and in vitro inhibitory potential against key enzymes relevant for hyperglycemia and hypertension of commonly used medicinal plants, herbs and spices in Latin America. Bioresour. Technol. 2010, 101, 4676–4689. [CrossRef] [PubMed]
24. Oboh, G.; Ademosun, A.O. Shaddock peels (Citrus maxima) phenolic extracts inhibit α-amylase, α-glucosidase and angiotensin I-converting enzyme activities: A nutraceutical approach to diabetes management. Diabetes Metab. Syndr. 2011, 5, 148–152. [CrossRef] [PubMed]
25. Epstein, M.; Sowers, J.R. Diabetes mellitus and hypertension. Hypertension 1992, 19, 403–418. [CrossRef] [PubMed]
26. Krogsgaard-Larsen, P.; Bundgaard, H. A Textbook of Drug Design and Development; Harwood Academic Publishers: Chur, Switzerland, 1991; pp. 302–307.
27. Erdos, E.G.; Skidgel, R.A. The angiotensin I-converting enzyme. Lab. Investig. 1987, 56, 345–348. [CrossRef] [PubMed]
28. Sun, H.X.; Wang, H. Immunosuppressive activity of the ethanol extract of Siegesbeckia orientalis on the immune responses to ovalbumin in mice. Chem. Biodivers. 2006, 3, 754–761. [CrossRef] [PubMed]
29. Wang, J.P.; Luo, Q.; Ruan, J.L.; Chen, Y.A.; Chen, M.X. Effect of Siegesbeckia orientalis L. on cervical cancer HeLa cell in vitro. Her. Med. 2009, 28, 45–46.
30. Chang, C.C.; Hsu, H.F.; Huang, K.H.; Wu, J.M.; Kuo, S.M.; Ling, X.H.; Houng, J.Y. Anti-proliferative effects of Siegesbeckia orientalis ethanol extract on human endometrial RL-95 cancer cells. Molecules 2014, 19, 19980–19994. [CrossRef] [PubMed]
31. Chang, C.C.; Ling, X.H.; Hsu, H.F.; Wu, J.M.; Wang, C.P.; Yang, J.F.; Fang, L.W.; Houng, J.Y. Siegesbeckia orientalis extract inhibits TGFβ1-induced migration and invasion of endometrial cancer cells. Molecules 2016, 21, 1021. [CrossRef] [PubMed]
32. Hong, Y.H.; Weng, L.W.; Chang, C.C.; Hsu, H.F.; Wang, C.P.; Wang, S.W.; Houng, J.Y. Anti-inflammatory effects of Siegesbeckia orientalis ethanol extract in in vitro and in vivo models. BioMed Res. Int. 2014, 329712. [CrossRef]
33. Nguyen, T.D.; Thuong, P.T.; Hwang, I.H.; Hoang, T.K.; Nguyen, M.K.; Nguyen, H.A.; Na, M. Anti-hyperuricemic, anti-inflammatory and analgesic effects of Siegesbeckia orientalis L. Resulting from the fraction with high phenolic content. BMC Complement. Altern. Med. 2017, 17, 191. [CrossRef] [PubMed]
34. Kaushik, G.; Satya, S.; Khandelwal, R.K.; Naik, S.N. Commonly consumed Indian plant food materials in the management of diabetes mellitus. Diabetes Metab. Syndr. Clin. Res. Rev. 2010, 4, 21–40. [CrossRef]
35. Kumar, S.; Narwal, S.; Kumar, V.; Prakash, O. α-Glucosidase inhibitors from plants: A natural approach to treat diabetes. Pharmacogn. Rev. 2011, 5, 19–29. [CrossRef] [PubMed]
36. Sheliya, M.A.; Rayhana, B.; Ali, A.; Pillai, K.K.; Aeri, V.; Sharma, M.; Mir, S.R. Inhibition of α-glucosidase by new prenylated flavonoids from Euphorbia hirta L. herb. J. Ethnopharmacol. 2015, 176, 1–8. [CrossRef] [PubMed]
37. Suresh, B.P.; Srinivasan, K. Amelioration of renal lesions associated with diabetes by dietary curcumin in streptootocin diabetic rats. Mol. Cell. Biochem. 1998, 181, 87–96.
38. Cai, Y.Z.; Sun, M.; Xing, J.; Luo, Q.; Corke, H. Structure–radical scavenging activity relationships of phenolic compounds from traditional Chinese medicinal plants. Life Sci. 2006, 78, 2872–2888. [CrossRef] [PubMed]
39. Yamagata, K.; Tagami, M.; Yamori, Y. Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 2015, 31, 28–37. [CrossRef] [PubMed]
40. Arts, I.C.W.; Hollman, P.C.H. Polyphenols and disease risk in epidemiologic studies. Am. J. Clin. Nutr. 2005, 81, 317S–325S. [PubMed]
41. Pandey, K.B.; Rizvi, S.I. Current understanding of dietary polyphenols and their role in health and disease. Curr. Nutr. Food Sci. 2009, 5, 249–263. [CrossRef]
42. Pandey, K.B.; Rizvi, S.I. Recent advances in health promoting effect of dietary polyphenols. Curr. Nutr. Food Sci. 2012, 8, 254–264. [CrossRef]
43. Anhea, F.F.; Desjardinsb, Y.; Pilona, G.; Dudonneb, S.; Genovesec, M.I.; Lajoloc, F.M. Polyphenols and type 2 diabetes: A prospective review. PharmaNutrition 2013, 1, 105–114. [CrossRef]
44. Palanisamy, U.; Ling, L.T.; Manaharan, T.; Appleton, D. Rapid Isolation of geraniin from Nephelium lappaceum rind waste and its anti-hyperglycemic activity. Food Chem. 2011, 127, 21–27. [CrossRef]
45. Wu, J.W.; Hsieh, C.L.; Wang, H.Y.; Chen, H.Y. Inhibitory effects of guava (Psidium guajava L.) leaf extracts and its active compounds on the glycation process of protein. Food Chem. 2009, 113, 78–84. [CrossRef]
46. Manaharan, T.; Teng, L.L.; Appleton, D.; Ming, C.H.; Masilamani, T.; Palanisamy, U.D. Antioxidant and antiglycemic potential of Peltophorum pterocarpum plant parts. Food Chem. 2011, 129, 1355–1361. [CrossRef]
47. Manaharan, T.; Appleton, D.; Cheng, H.M.; Palanisamy, U.D. Flavonoids isolated from Syzygium aqueum leaf extract as potential antihyperglycaemic agents. Food Chem. 2012, 132, 1802–1807. [CrossRef]
48. Dong, H.Q.; Li, M.; Zhu, F.; Liu, F.L.; Huang, J.B. Inhibitory potential of trilobatin from Lithocarpus polystachyus Rehd against α-glucosidase and α-amylase linked to type 2 diabetes. Food Chem. 2012, 130, 261–266. [CrossRef]
49. Lushchak, V.I. Freeradicals, reactive oxygen species, oxidative stress and its classification. Chem. Biol. Interact. 2014, 224, 164–175. [CrossRef] [PubMed]
50. Kiselova, Y.; Ivanova, D.; Chervenkov, T.; Gerova, D.; Galunska, B.; Yankova, T. Correlation between the in vitro antioxidant activity and polyphenol content of aqueous extracts from Bulgarian herbs. Phytother. Res. 2006, 20, 961–965. [CrossRef] [PubMed]
51. Tsai, Y.D.; Hsu, H.F.; Chen, Z.H.; Wang, Y.T.; Huang, S.H.; Chen, H.J.; Wang, C.P.; Wang, S.W.; Chang, C.C.; Houng, J.Y. Antioxidant, anti-inflammatory, and anti-proliferative activities of extracts from different parts of farmed and wild Glossogyne tenuifolia. Ind. Crop. Prod. 2014, 57, 98–105. [CrossRef]
52. Zhang, L.S.; Wang, X.; Dong, L.L. Antioxidation and antiglycation of polysaccharides from Misgurnus anguillicaudatus. Food Chem. 2011, 124, 183–187. [CrossRef]
53. Kwon, G.J.; Choi, D.S.; Wang, M.H. Biological activities of hot water extracts from Euonymus alatus leaf. Korean J. Sci. Technol. 2007, 39, 569–574.
54. Oboh, G.; Akinyemi, A.J.; Ademiluyi, A.O. Inhibition of α-amylase and α-glucosidase activities by ethanolic extract of Telfairia occidentalis (fluted pumpkin) leaf. Asian Pac. J. Trop. Biomed. 2012, 2, 733–738. [CrossRef]
55. Jung, H.A.; Yung, Y.J.; Na, Y.Y.; Jeong, D.M.; Bae, H.J.; Kim, D.W.; Na, D.H.; Choi, J.S. Inhibitory effects of Nelumbo nucifera leaves on rat lens aldosereductase, advanced glycation endproducts formation, and oxidative stress. Food Chem. Toxicol. 2008, 46, 3818–3826. [CrossRef] [PubMed]
56. Cheplick, S.; Kwon, Y.I.; Bhowmik, P.; Shetty, K. Phenolic-linked variation in strawberry cultivars for potential dietary management of hyperglycemia and related complications of hypertension. Bioresour. Technol. 2010, 101, 404–413. [CrossRef] [PubMed]
57. Ramdath, D.D.; Padhi, E.; Hawke, A.; Sivaramalingam, T.; Tsao, R. The glycemic index of pigmented potatoes is related to their polyphenol content. Food Funct. 2014, 5, 909–915. [CrossRef] [PubMed]
58. Worsztynowicza, P.; Napierała, M.; Białasa, W.; Grajeka, W.; Olkowicz, M. Pancreatic α-amylase and lipase inhibitory activity of polyphenolic compounds present in the extract of black chokeberry (Aronia melanocarpa L.). Process Biochem. 2014, 49, 1457–1463. [CrossRef]
59. Lacaille-Dubois, M.A.; Franck, U.; Wagner, H. Search for potential angiotensin converting enzyme (ACE)-inhibitors from plants. Phytomedicine 2001, 8, 47–52. [CrossRef] [PubMed]
60. Oboh, G.; Ademosun, A.O. Phenolic extracts from grape fruit peels (Citrus paradisi) inhibit key enzymes linked with type 2 diabetes and hypertension. J. Food Biochem. 2011, 35, 1703–1709. [CrossRef]
61. Sakulnarmrat, K.; Konczak, I. Composition of native Australian herbs polyphenolic-rich fractions and in vitro inhibitory activities against key enzymes relevant to metabolic syndrome. Food Chem. 2012, 134, 1011–1019. [CrossRef] [PubMed]
62. Sreerama, Y.N.; Sashikala, V.B.; Pratape, V.M. Phenolic compounds in cowpea and horse gram flours in comparison to chickpea flour: Evaluation of their antioxidant and enzyme inhibitory properties associated with hyperglycemia and hypertension. Food Chem. 2012, 133, 156–162. [CrossRef]
63. Santana-Gálvez, J.; Cisneros-Zevallos, L.; Jacobo-Velázquez, D.A. Chlorogenic acid: Recent advances on its dual role as a food additive and a nutraceutical against metabolic syndrome. Molecules 2017, 22, 358. [CrossRef] [PubMed]
64. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of chlorogenic acid on regulating glucose and lipids metabolism: A review. Evid. Based Complement. Alternat. Med. 2013, 2013, 801457. [CrossRef] [PubMed]
65. Pei, K.; Ou, J.; Huang, J.; Ou, S. p-Coumaric acid and its conjugates: Dietary sources, pharmacokinetic properties and biological activities. J. Sci. Food Agric. 2016, 96, 2952–2962. [CrossRef] [PubMed]
66. Rasouli, H.; Hosseini-Ghazvini, S.M.; Adibi, H.; Khodarahmi, R. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: A virtual screening perspective for the treatment of obesity and diabetes. Food Funct. 2017, 8, 1942–1954. [CrossRef] [PubMed]
67. Syama, H.P.; Arya, A.D.; Dhanya, R.; Nisha, P.; Sundaresan, A.; Jacob, E.; Jayamurthy, P. Quantification of phenolics in Syzygium cumini seed and their modulatory role on tertiary butyl-hydrogen peroxide-induced oxidative stress in H9c2 cell lines and key enzymes in cardioprotection. J. Food Sci. Technol. 2017, 54, 2115–2125. [CrossRef] [PubMed]
68. Oboh, G.; Isaac, A.T.; Akinyemi, A.J.; Ajani, R.A. Inhibition of key enzymes linked to type 2 diabetes and sodium nitroprusside induced lipid peroxidation in rats’ pancreas by phenolic extracts of avocado pear leaves and fruit. Int. J. Biomed. Sci. 2014, 10, 208–216. [PubMed]
69. Hsu, H.F.; Chang, S.F.; Chen, Z.H.; Yuan, S.S.F.; Tsai, Y.D.; Wang, C.P.; Wang, S.W.; Fang, L.W.; Houng, J.Y. Cytotoxic effect of Anisomeles indica extract on human pharynx squamous cancer cells. J. Med. Plants Res. 2012, 6, 5002–5012. [CrossRef]
70. Patra, J.K.; Das, G.; Baek, K.H. Chemical composition and antioxidant and antibacterial activities of an essential oil extracted from an edible seaweed, Laminaria japonica L. Molecules 2015, 20, 12093–12113. [CrossRef] [PubMed]
71. Oyaizu, M. Studies on products of browning reaction: Antioxidative activity of products of browning reaction prepared from glucosamine. J. Nutr. 1986, 44, 307–315. [CrossRef]
72. McDougall, G.J.; Nimish, N.; Kulkarni, N.N.; Stewart, D. Berry polyphenols inhibit pancreatic lipase activity in vitro. Food Chem. 2009, 115, 193–199. [CrossRef]
73. Cushman, D.W.; Cheung, H.S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 1971, 20, 1637–1648. [CrossRef]